Cargando…
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
The history of ascorbic acid (AA) and cancer has been marked with controversy. Clinical studies evaluating AA in cancer outcome continue to the present day. However, the wealth of data suggesting that AA may be highly beneficial in addressing cancer-associated inflammation, particularly progression...
Autores principales: | Ichim, Thomas E, Minev, Boris, Braciak, Todd, Luna, Brandon, Hunninghake, Ron, Mikirova, Nina A, Jackson, James A, Gonzalez, Michael J, Miranda-Massari, Jorge R, Alexandrescu, Doru T, Dasanu, Constantin A, Bogin, Vladimir, Ancans, Janis, Stevens, R Brian, Markosian, Boris, Koropatnick, James, Chen, Chien-Shing, Riordan, Neil H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061919/ https://www.ncbi.nlm.nih.gov/pubmed/21375761 http://dx.doi.org/10.1186/1479-5876-9-25 |
Ejemplares similares
-
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
por: Wagner, Samuel C, et al.
Publicado: (2014) -
Circulating endothelial progenitor cells: a new approach to anti-aging medicine?
por: Mikirova, Nina A, et al.
Publicado: (2009) -
Anti-angiogenic effect of high doses of ascorbic acid
por: Mikirova, Nina A, et al.
Publicado: (2008) -
Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients
por: Mikirova, Nina, et al.
Publicado: (2013) -
Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects
por: Mikirova, Nina A, et al.
Publicado: (2010)